Corinne Epperly
CIK 1839156 · last filed 2026-05-12
Corinne Epperly is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for INAB, was dated May 12, 2026. Current disclosed insider exposure totals $117.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$117.2K
2
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INAB | Director | 81,967 | $1.43 | $117.2K | $0 | 8 | 2026-05-12 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | — | $15.00 | — | $0 | 4 | 2023-01-19 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-12 | INAB | Grant (A) | — | $0 | EDGAR |
| 2025-05-12 | INAB | Grant (A) | — | $0 | EDGAR |
| 2025-05-07 | INAB | Mixed | — | $0 | EDGAR |
| 2024-12-23 | INAB | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | INAB | Grant (A) | — | $0 | EDGAR |
| 2024-02-08 | INAB | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | INAB | Grant (A) | +81,967 | $0 | EDGAR |
| 2023-12-08 | INAB | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-06-08 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |